EP Patent

EP0375063A1 — Granulates for multiparticulate controlled-release oral compositions

Assigned to Astellas Pharma Europe BV · Expires 1990-06-27 · 36y expired

What this patent protects

Granulates for multiparticulate controlled-release oral compositions comprising biologically active substances in solid dispersion with an acid-resistance and/or release-­limiting compound, the solid dispersion being mixed with water-insoluble carrier particles, and the preparati…

USPTO Abstract

Granulates for multiparticulate controlled-release oral compositions comprising biologically active substances in solid dispersion with an acid-resistance and/or release-­limiting compound, the solid dispersion being mixed with water-insoluble carrier particles, and the preparation of such granulates. Preferred biologically active substances are corticosteroids, non-steroidal anti-inflammatory drugs and bismuth compounds. The granules have a preferred particle size of less than 1 mm.

Drugs covered by this patent

Patent Metadata

Patent number
EP0375063A1
Jurisdiction
EP
Classification
—
Expires
1990-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Astellas Pharma Europe BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.